Rusan Pharma is an API and finished-dose manufacturer based in India. It holds 4 active US drug master files and 10 valid CEPs across a filed portfolio of 10 molecules. Its filings concentrate with UZPHARM (UZ), DAV (Vietnam) and RAMA (GE). Its GMP standing is certified by ANVISA (Brazil), CDSCO (India) and EMA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 3 May 2024 as VAI. Customs aggregates show $25.4M of exports covering 473 molecules to 47 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Kutch 370230, United Arab Emirates | Not on file |
| DEHRADUN, India | Not on file |
| ate ankleshwarankleshwar 393 002 bharuch, India | Not on file |
| Gidc, India | Not on file |
| Mumbai, India | Not on file |
| GUJARAT, India | Not on file |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Buprenorphine | EDQM | 2 |
| Eflornithine | US FDA | 2 |
| Fentanyl | EDQM | 2 |
| Nalmefene | US FDA | 2 |
| Apomorphine | EDQM | 1 |
| Bisoprolol | EDQM | 1 |
| Diazepam | EDQM | 1 |
| Methadone | EDQM | 1 |
| Naloxone | EDQM | 1 |
| Naltrexone | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| UZPHARM (UZ) | 41 | None |
| DAV (Vietnam) | 5 | None |
| RAMA (GE) | 5 | None |
| CDSCO (India) | 3 | 5 |
| NMRC (NA) | 2 | None |
| MINSA (CR) | 2 | None |
| ANVISA (Brazil) | None | 5 |
| EMA | None | 4 |
| NCELS (KZ) | None | 1 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.4M | 8 |
| 2025 | Not reported | $25.4M | 47 |
| 2024 | Not reported | $29.8M | 47 |
| 2023 | Not reported | $20.7M | 50 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Rusan Pharma comes back tiered against every other supplier able to file there.
Start for free